Jul 16, 2026 06:00PM
Jul 16, 2026 06:00PM
Jul 12, 2026 07:00PM
Jun 24, 2026 03:14AM
Jun 24, 2026 03:05AM
Jun 15, 2026 12:00PM
Jun 11, 2026 07:00AM Takeda's zasocitinib beats deucravacitinib in psoriasis study
Jun 11, 2026 07:00AM
Jun 9, 2026 04:30PM
Jun 9, 2026 04:30PM
May 13, 2026 05:46AM
May 13, 2026 02:38AM
May 4, 2026 08:00AM
May 4, 2026 08:00AM Takeda Announces Positive Topline Results from Pivotal Phase 2/3 Clinical Trial of TAK-881 in Primary Immunodeficiency Disease (PID)
Mar 30, 2026 04:21AM
Mar 28, 2026 03:00PM
Mar 2, 2026 06:01AM
Mar 2, 2026 02:00AM
Feb 19, 2026 12:00PM
Feb 19, 2026 12:00PM
Feb 10, 2026 04:50AM FDA accepts Takeda drug application for narcolepsy treatment
Feb 10, 2026 03:15AM
Jan 29, 2026 01:37AM
Jan 22, 2026 07:45AM
Jan 22, 2026 07:45AM
Jan 14, 2026 09:00AM
Jan 5, 2026 07:03AM
Jan 5, 2026 07:00AM Takeda and Protagonist Announce Submission of New Drug Application (NDA) for Rusfertide for Treatment of Polycythemia Vera (PV)
Dec 18, 2025 03:00AM
Dec 18, 2025 03:00AM
Dec 8, 2025 02:54AM
Dec 6, 2025 09:30AM
Nov 7, 2025 11:01AM
Nov 7, 2025 11:00AM
Nov 3, 2025 08:33AM Takeda reports 7-year dengue vaccine data showing sustained protection
Nov 3, 2025 07:00AM
Oct 30, 2025 03:04AM
Oct 27, 2025 08:35AM
Oct 21, 2025 08:25PM
Oct 21, 2025 08:25PM
Sep 23, 2025 06:04PM
Sep 16, 2025 08:02AM Takeda partners with VELA for wind-powered pharmaceutical shipping
Sep 16, 2025 08:00AM
Sep 11, 2025 08:45AM
Sep 11, 2025 08:45AM
Sep 8, 2025 03:00AM
Sep 8, 2025 03:00AM
Sep 5, 2025 08:45PM
Sep 5, 2025 08:45PM U.S. FDA Approves Expanded Indication for VONVENDI® [von Willebrand factor (Recombinant)] for Adults and Children with Von Willebrand Disease
Jul 30, 2025 02:41AM

1,171,485 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All